Potential drug-drug interactions and their associated factors in hospitalized COVID-19 patients with comorbidities.

ABSTRACT:

Background

Hospitalized COVID-19 patients with comorbidities receive more complex drug therapy. This increases the probability of potential drug-drug interactions (pDDIs). Studies on pDDIs in hospitalized patients with COVID-19 in countries with limited resources like Indonesia during the later period of the disease are still limited. This study aims to identify the pattern of pDDIs in hospitalized COVID-19 patients with comorbidities and their associated factors, especially in the second wave of the disease in Indonesia.

Methods

This study was a longitudinal-retrospective study observing hospitalized COVID-19 patients with comorbidities using medical record data in June-August 2021 at a public hospital in a region in Indonesia. pDDIs were identified using the Lexicomp^®

SUBMITTER: Rahmadani ID 

PROVIDER: S-EPMC10314741 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature